Assertio Investor Relations Material
Latest events
Q4 2023
Assertio
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Assertio Holdings Inc
Access all reports
Segment Data
Access more data
Product sales by
Product
INDOCIN products
CAMBIA
Otrexup
SPRIX
Other
Expenses by
Financials
Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital and pain, and inflammation. The Company's neurology products are used to treat central nervous system disorders such as attention deficit hyperactivity disorder (ADHD), Parkinson's disease and epilepsy. Its hospital unit is involved in manufacturing injectable general solutions for parenteral nutrition applications. Its pain and inflammation business develops prescription topical creams that are used to treat various inflammatory joint-pain related symptoms.
Latest articles
Sundar Pichai: CEO of Alphabet and Google
Explore Sundar Pichai's improbable journey from Chennai, India, to becoming one of the most powerful individuals on the planet.
19 Apr 2024
The Three Cornerstones of Serial Acquirer Success
Explore what is behind successful serial acquirers: efficient capital use, decentralization, and a strong focus on people.
19 Apr 2024
Companies That Had Their IPO in 2023: Cautious Optimism
The cautiously optimistic market in 2023 saw stocks rebounded upwards, and interest in IPOs picked up from the previous year.
15 Apr 2024
Ticker symbol
Country
🇺🇸 United States